Dr. Shashi Gujar

A cancer immunotherapy innovator and Dalhousie’s Executive Director of Cancer Immunotherapy, Innovation and Global Partnerships, Dr. Gujar leads internationally connected research harnessing oncolytic viruses, immunology, and precision medicine to develop more targeted approaches to cancer diagnosis, prevention, and treatment.